Skip to menu Skip to content Skip to footer

The evaluation of MEK inhibition as a therapeutic strategy for childhood acute myeloid leukaemia (2013-2016)

Experts

Dr Andy Moore

ATH - Associate Professor
Child Health Research Centre
Faculty of Medicine
Andy Moore
Andy Moore